Restricted Access  •  HBIL3C
Camden Social Impact Bond
Camden Social Impact Bond Fund, LP • Reg D Private Offering
CONFIDENTIAL  •  REG D PRIVATE OFFERING Pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933, as amended • Accredited Investors only (Rule 501 of Reg D) • Not registered with the SEC • General solicitation permitted under Rule 506(c) — verification required
The information contained herein is provided for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security, investment product, or investment strategy. Any such offer or solicitation will be made only pursuant to definitive offering documents and in accordance with applicable securities laws.

The views expressed reflect the current perspectives of Human Biology Investments, L3C (“HBIL3C”) and are subject to change without notice. Any references to targeted returns, IRR, MOIC, or other performance metrics are forward-looking and not guarantees of future performance. Actual results may differ materially due to payout timing risk, political and regulatory factors, counterparty credit risk, evaluation outcomes, and other factors beyond the control of HBIL3C.

Descriptions of the HBIL3C Impact Volatility Index (IVNDX™), Impact Liquidity, outcome-contingent contracts, and any potential future derivative instruments are conceptual and prospective in nature. No index, derivative, swap, option, futures contract, or exchange-traded product referenced herein is currently offered or available, and any future development would be subject to regulatory approvals, market infrastructure, and legal considerations.

Nothing herein constitutes investment, legal, tax, or accounting advice. Prospective investors should consult their own advisors before making any investment decision. Human Biology Investments, L3C is currently exempt from registration as an investment adviser under applicable provisions of the U.S. Investment Advisers Act of 1940.

For government officials, agency evaluators, policy researchers, and institutional counterparties: This simulation is provided solely for analytical and informational review in connection with the Camden Social Impact Bond pre-development process. It does not constitute a grant application, a procurement submission, or a binding proposal. All projected outcomes, cost estimates, and fiscal impact figures are model-based and subject to independent evaluation and verification in accordance with applicable federal and state program requirements.

All methodologies, frameworks, indices, terminology, and intellectual property described herein — including Value Quantification, Biomimetic Hedging, Impact Volatility, and IVNDX™ — are proprietary to Human Biology Investments, L3C and may not be reproduced, distributed, or used without prior written consent. Past performance is not indicative of future results.

// ACCESS NOT GRANTED

This environment is restricted to qualified investors, institutional counterparties, and authorized government personnel.
You may close this window.

Camden Social Impact Bond
Live US Public Debt
fiscaldata.gov
2066 IVNDX-Adj D/G
V₀ˢʸⁿ — PV Surplus
Syntropy-adjusted 5yr
SIPPRA Net BCA Benefit
at selected tier
Camden SIB Fund (cumul.)
N municipalities · 2026–2066
IVNDX™ Social Impact Scorecard — Camden
I_{Camden,t} = Σ_{d,g} ω_{d,g} · I_{d,g,t} · five signal components · real-time weight × contribution · EQ 11 decomposition
Overall IVNDX™ Signal I_{Camden}
Composite of 5 factors · Camden social/fiscal domain · updates with sliders
Camden Baseline Failure Process — State-Aid Dependency vs. IVNDX™ Offset
NJ structural dependency cost simulation · dBₜ = μBₜ dt + σBₜ dWₜ − θIₜ dt · Camden lives on NJ balance sheet — NJ is the outcome payer · ACA 2010 preSIPPRA · SIPPRA 2018 · SIB 2026 · SIPPRA outcome payments eligible 2028+ · 2006–2046 · Sω convergence target: 2036–2046
Camden SIB Fund — NJDCA Memo 1 & 2 Extrapolated
2006–2025: Structural deficit era + NJ Transitional Aid (state dependency) · 2026–2031: Camden SIB annual surplus (Capital Physics S_t‑synced) + cumulative · 2032–2046: Fiscal autonomy era · TA declines to $0 as SIB cumulative overtakes historical gap · NJDCA Memo 1 + 2
Sources: Camden City Adopted Municipal Budgets FY2006–FY2025 (NJ DLGS); NJ Transitional Aid to Municipalities award letters (NJDCA, 2006–2025); Camden CY2025/FY2026 TA Application (filed March 4, 2025). Projections 2026–2046: IVNDX™ model (Human Biology Investments, L3C). Results are model-based and not guaranteed.
NJDCA Memo #1 — Transitional Aid Dependency Framework (2006–2025)
Camden City's structural reliance on NJ Department of Community Affairs (NJDCA) Transitional Aid · Root cause of fiscal entropy · Pre-condition for SIB intervention · 2 CFR 200 federal pass-through foundation
1 — Transitional Aid History (2006–2025)

NJDCA administered NJ Transitional Aid to Municipalities (TAM) annually. Camden received $40M–$68M/yr throughout this period, peaking at approximately $68M in FY2013 and stabilizing near $40–46M/yr by FY2020–2025. This aid represented 17–29% of Camden's total annual appropriations, creating a structural dependency that suppressed the development of autonomous fiscal capacity. The IVNDX model treats the TAM trajectory as the primary driver of fiscal entropy H_{d,g,t}. Source: NJ DLGS Transitional Aid award letters, Camden City adopted budgets (FY2006–FY2025).

2 — Structural Deficit Architecture

Between 2006 and 2025, Camden operated with a recurring structural deficit averaging $35–50M/yr, bridged entirely by Transitional Aid. The FY2025 budget reflects $234.8M total appropriations with $147.8M in state aid (63%), $31.5M local tax levy, and $22.2M surplus — a fiscal architecture with no autonomous recovery path absent structural intervention. The Camden Trust Fund Reserve is fully exhausted as of FY2025 and projected at −$35.8M by 2030 without IVNDX intervention. Source: Camden City FY2025 Municipal Budget, NJ DLGS filing March 4, 2025; Camden City FY2026 Transitional Aid Application CY2025/FY2026.

3 — NJDCA's Role as Prime Recipient

Under federal grant law (2 CFR 200), NJDCA serves as the prime recipient of federal pass-through appropriations directed at Camden City social programs. Camden receives funds as a subrecipient. This legal relationship — prime recipient/subrecipient — forms the structural basis of the SIB's outcome-contract architecture. Reclassifying Camden as a municipal outcome allocator (per Memo #2) requires documented performance under this prime/sub structure, which NJDCA Memo #1 establishes as the pre-existing baseline. Source: 2 CFR 200 (Uniform Guidance); NJ DLGS TAM program documentation.

4 — Camden SIB Pre-Development Condition

NJDCA Memo #1 establishes the pre-development condition for the Camden Social Impact Bond: the documented failure trajectory of the state-aid-dependent municipal budget architecture is a prerequisite for SIPPRA eligibility. A BCA (Benefit-Cost Analysis) submitted to the federal SIPPRA program office must demonstrate that without intervention, the status quo produces measurable social harm and fiscal deterioration — which the Transitional Aid dependency baseline provides in full. The IVNDX model uses this 20-year data record as the H⁰ (no-intervention entropy baseline). Source: OMB SIPPRA Program Guidance (FY2021–FY2025); NJDCA TAM Program Rules.

NJDCA TAM: 2006–2025 2 CFR 200 — Prime/Sub Structure IVNDX H⁰ Baseline Input SIPPRA BCA Pre-Condition NJ DLGS Camden Budget Record
NJDCA Memo #2 — Impact Office(r) Strategy (Dec 16, 2024 → March 2, 2026)
Camden City shifts from recipient of state stabilizationmunicipal allocator of outcome contracts · Target: 35% outcome-based sub-expenditure by Year 5 · Replicable across all high-dependency municipalities · Each municipality becomes a domain node in the national Iₜ = Σ_{d,g} ω_{d,g} I_{d,g,t} aggregate
A — True Novation / Assignment

The state formally exits as counterparty and Camden City steps in. Vendor acknowledgment is signed, legally transferring the contract relationship. Camden gains full control of scope definition, performance standards, reporting schedules, remedies for non-performance, and renewal terms. This is the most structurally powerful strategy — every dollar of state-funded vendor spend becomes a city-directed outcome contract. Best applied to discrete, bounded programs (e.g. re-entry housing, youth workforce) where NJDCA has historically acted as a pass-through purchaser with no value-based conditions. Estimated exposure under Strategy A: $40M–$60M in Camden-adjacent vendor contracts, immediately SIPPRA-eligible once BCA milestones are verified.

B — Delegated Administration

NJDCA retains the contract but issues a formal delegation letter authorizing Camden’s Impact Office(r) to manage day-to-day procurement, vendor oversight, and outcome enforcement. The state pays on schedule conditioned on municipal compliance — gradually shifting fiscal responsibility downward while preserving state legal standing. This strategy is ideal as an on-ramp for programs currently mid-contract or bound by federal pass-through restrictions that preclude full novation. The delegation mechanism creates a documented record of municipal performance that supports a future transition to Strategy A. The Impact Office(r) builds institutional credibility and IVNDX data sovereignty through this phase — which is critical for SIPPRA federal guarantee applications.

C — Pass-Through Subrecipient

NJDCA, NJDOH, NJDOC, or NJDOE remains the prime recipient of federal and state appropriations. Camden City formally becomes a subrecipient — a recognized legal status under federal grant law (2 CFR 200) — and sub-grants those funds to service providers using outcome-contingent subaward agreements. Performance terms are defined at the activity level, not merely by inputs or deliverables. This is the highest-leverage strategy for Camden: it brings $140M–$180M+ in annual state agency vendor expenditure under IVNDX-aligned measurement architecture, all legally structured, federally recognized, and SIPPRA-eligible. Under this model, Camden becomes the outcome payment intermediary — the functional equivalent of a municipal Social Finance intermediary with full legal standing.

D — Parallel Performance Rider

While existing state contracts remain in place, the Impact Office(r) executes a parallel performance rider — a legally binding side agreement — attached to active vendor contracts. The rider mandates: data-sharing with the IVNDX measurement platform, clearly defined outcome metrics at the city budget-channel level, operational controls vested in Camden, and wraparound funds contingent on verified performance. This strategy is deployable immediately without waiting for contract expiration or vendor consent to novation. It creates a shadow IVNDX data layer over existing spending — generating the BCA-verified savings records needed for SIPPRA qualification and laying the legal groundwork for future Strategy A novation. Strategy D is the fastest path to IVNDX data sovereignty and the foundation of the SIB investor return thesis.

Layer 1 — City Outcomes Procurement Code Layer 2 — Standardized Contract Architecture Layer 3 — Municipal Outcome Payment Utility Outcomes Reserve + Multi-Year Payment Line SIPPRA Phase 2 — NJ + Adjacent States Phase 3 — IVNDX-Linked Notes + ETPs
LP Capture Scenario — Impact Office(r) Effect on SIB Economics
Base SIB Floor
$40M
85% LP capture = $34M distributed · without Impact Office(r) · savings floor only
With Impact Office(r)
$140M–$180M+
Pass-through sub-recipient model unlocks NJ DCA + NJDOH + NJDOE + NJDOC spend · outcome-contingent · 3-5× multiplier
LP Upside (85% of $180M)
$153M+
vs $34M base · 4.5× LP return amplification · SIPPRA federal backstop on verified outcomes
Why the Multiplier Works
The Impact Office(r) converts Camden from a state check-receiver into a municipal outcome allocator. Under Strategy C (Pass-Through Subrecipient), NJ DCA becomes prime recipient of state/federal funds and Camden sub-grants with outcome-contingent terms. This brings $140M–$180M+ in annual state vendor spend under IVNDX-aligned performance architecture — all measured, verified, and SIPPRA-eligible.
SIPPRA + Impact Office Flywheel
BCA-verified savings from Impact Office(r)-managed outcomes qualify for SIPPRA federal guarantee coverage (post-2028 once BCA review cycles complete). Camden becomes the first municipality with a fully integrated municipal outcome payment utility — generating verified surplus at both the local and NJ state balance-sheet level. NJ is the outcome payer; SIPPRA is the federal backstop.
Capital Physics: The Crossing Point
When Surplus Curve S_t Overtakes Capital Curve K_t = Compounding Regime · dS/dK > 1 · HBIL3C · Camden SIB 60-month term
CAPITAL PHYSICS THEORY

Capital deployment K_t follows a logarithmic decay curve — most capital is absorbed early (infrastructure, onboarding, pilot friction) and decelerates as the program matures. The verified surplus curve S_t begins slowly due to outcome measurement lag (ℓ), then inflects sharply once IVNDX™ intervention validates, creating an exponential compounding regime.

The Crossing Point is the month where S_t = K_t — surplus generated equals capital invested. After this inflection, every additional dollar of verified savings exceeds its cost basis (dS/dK > 1). This is the entry to the Compounding Regime: surplus self-reinforces through Syntropy Ω, entropy reduction lowers future capital requirements, and the IVNDX™ offset permanently bends Camden’s dependency curve.

For the Camden SIB: K_total = u × 5 (5-year capital deployed). Critically, K_t does not plateau — it peaks near month 18–22 then bends downward as verified savings begin recycling back into the system, displacing new capital requirements. By month 50–60, remaining capital obligation falls to the 25–75M residual range (oversight, compliance, and measurement operations). S_t compounding begins at month ~24 once BCA milestone verification is complete, and is calibrated to a pragmatic ceiling of ~$300M by month 60 — reflecting phased realization across Camden's budget channels rather than theoretical maximum. The crossing point occurs near month ~37, yielding a net surplus advantage within the 60-month SIB term — the structural basis for the 18.5%+ LP IRR target and the SIPPRA federal guarantee eligibility threshold.

Model: S_t (surplus curve) anchored to Camden FY2025 actuals ($22.2M surplus floor) and IVNDX™ Capital Physics equations. K_t (capital threshold) derived from structural deficit trajectory per NJ DLGS Camden audits. Crossing Point = fiscal autonomy threshold month. Source: Human Biology Investments, L3C proprietary IVNDX™ framework; NJ DLGS Camden City Audit FY2025.
Indirect Fiscal Surplus Channels — Verified Surplus S Components
Camden NJ municipal budget basis 2006–SIB fund end · S_{d,g,t} = q·m·(C(X⁰) − C(Xᴵ))₊ · channel values derived from Camden City budget + NJDCA Transitional Aid programming · SIB fund duration only
NCD Prevention → Medicaid ↓
Plant-based nutrition + FQHC care reduces chronic disease rates. Medicaid reimbursement falls. CMS outlay shrinks — maps directly to C(Xᴵ) < C(X⁰) in health domain.
Reentry Success → Tax Base ↑
Reduced recidivism generates earned income. Federal/state tax revenue rises. EITC and SNAP dependency falls — verified surplus in criminal justice domain.
Education Gains → Remedial ↓
Plant-based school meals reduce special ed referrals. DOE per-pupil cost drops. Academic gains compound — education domain C(Xᴵ) reduction over ℓ-lag.
Aid Dependency ↓ → Autonomy ↑
20% aid dependency reduction target by Year 5. State/fed transfers shrink. Municipality self-generates surplus via local levy + host fees — entropy reduction Ω compounds over time.
Sources: NJDOE — NJ Dept. of Education Camden City School District per-pupil allocations (FY2006–FY2025); NJDOC — NJ Dept. of Corrections Camden-vicinage cost-per-incarcerated-person data; NJDOH — NJ Dept. of Health Camden County uncompensated care & hospital utilization reports; NJDCA — Transitional Aid award letters (2006–2025). All values are within the Camden, NJ vicinage. Projections are model-based.
Camden SIB — Verified Surplus S_{d,g,t}
S = q·m·(C(X⁰) − C(Xᴵ))₊ · floor $40M · $20M AUM · 18.5%+ IRR · 60-month · outcome payment = α × verified savings · no SIPPRA amplification
$40M+
5-Yr Savings Floor
18.5%
Target IRR
V₀ˢʸⁿ (Syntropy PV)
ℰ Capital Efficiency
Convex Government Cost Map — Camden
C_{d,g}(X) = c₀ + c₁X + c₂X² + c₃X³ · as disorder worsens, cost accelerates non-linearly · IVNDX flattens the curve by reducing X toward the intervention-adjusted baseline Xᴵ
↔ Drag the X⁰ ball or Xᴵ ball left/right along the cost curve to explore ΔC
Model: C(X) = c₁X + c₂X² + c₃X³ — cubic convex cost function per IVNDX™ proprietary equations (Human Biology Investments, L3C). X⁰ = no-intervention disorder level; Xᴵ = IVNDX-adjusted disorder after SIB intervention. ΔC = verified savings basis for SIPPRA BCA.
Fiscal Entropy — Camden Baseline
H_{d,g,t} = −Σᵢ pᵢ ln pᵢ · entropy of future cost-state distribution · higher = more disorder
Syntropy Ω — IVNDX Entropy Reduction
Ω = H⁰ − Hᴵ · how much IVNDX intervention reduces fiscal disorder · amplifies V₀ˢʸⁿ via e^{βΩ}
SIPPRA Federal Guarantor — Allocation Tiers & Replenishment Model
$100M appropriated FY2018 (enacted Feb 9, 2018) · Round 1 awards Mar–Dec 2021 ($38.9M, 4 projects) · Round 2 awards Dec 12, 2024 ($46.9M, 6 projects) · BCA-verified outcome payments begin 2026+ · IVNDX replication triggers Congressional replenishment (aspirational)
Sources: SIPPRA Program — Social Impact Partnerships to Pay for Results Act, enacted Feb 9, 2018 (Bipartisan Budget Act, Pub. L. 115-123). FY2018 appropriation: $100M (one-time). Round 1 awards (Apr 2021): 4 awardees, ~$27.8M project grants. Round 2 awards (Dec 12, 2024): 6 awardees, $46.9M. Round 3 NOFO: draft published, comments due May 11, 2026. Source: fiscaldata.treasury.gov; OMB SIPPRA program documentation; Treasury.gov Press Release Dec 12, 2024.
Debt-to-GDP Path — Three Scenarios vs. IVNDX™ Adjustment
Federal gross debt as % GDP · 1926–2025 historical actuals (OMB Table 7.1 / CBO) + 2026–2066 simulation · Baseline failure process dBₜ = μBₜ dt + σBₜ dWₜ − θIₜ dt · Camden HBIL3C testbed
Sources: U.S. Debt-to-GDP 1926–2025: OMB Historical Tables Table 7.1; Federal Reserve FRED GFDEGDQ188S; CBO Budget and Economic Outlook 2025–2035; BEA GDP series. Projections 2026–2066: CBO Long-Term Budget Outlook (2025); IVNDX™ adjustment scenario is proprietary and model-based (Human Biology Investments, L3C). Actual fiscal outcomes may differ materially.
Annual Debt Service Cost
Net interest payments as % GDP · 2006–2025 FRED actuals (FYOIGDA188S) + 2026–2066 scenarios · 2025: 3.15% (post-WWII high) · CBO projects 4.6% by 2036
IVNDX™ Cumulative Relief + SIPPRA Coverage
SIPPRA: $100M enacted Feb 2018 · R1 awards 2021 ($38.9M, 4 projects) · R2 awards Dec 2024 ($46.9M, 6 projects) · $74M+ committed to 10 awardees · IVNDX™ cumulative fiscal relief crescendo: Camden pilot 2026 → state-level replication 2031 → national impact 2041–2046+
National Debt Trajectory — IVNDX-Guided vs. Current Path
US gross federal debt historical (1926–2025) · 100 years of verified debt data (TreasuryDirect / OMB Table 7.1 / FRED GFDEBTN) + IVNDX-guided intervention scenario vs. current trajectory · Fund I/II/III milestones · diverging paths widen through 2066 · IVNDX avoids ~$86T in debt accumulation
USD Convexity vs. Taxdollar Value
USD purchasing power 1926–2066 (full century + projection) · Taxdollar Value: quality-adjusted citizen value per tax dollar across society / environment / commerce / industry · adjacent to USD but not equivalent · convex relationship · IVNDX TDV recovery begins 2036
Annual Simulation Data — 2026–2066
All figures derived from IVNDX™ proprietary equations · Social domain d = Social · geography g = Camden, NJ
YearGDP ($T)Debt ($T) Stagnation D/GConsensus D/GExpansion D/G IVNDX D/GSvc Cost % X⁰ Baseline ($M)Xᴵ Adjusted ($M) S Verified SurplusH EntropyΩ Syntropy V₀ˢʸⁿ ($M)SIPPRA Fund
Model Foundation — IVNDX™ Core Equations
All simulation math derives strictly from these proprietary equations · Human Biology Investments, L3C
Core Stochastic · Baseline Failure
dBₜ = μBₜ dt + σBₜ dWₜ − θIₜ dt
B = high-cost baseline (state-aid dependency) · μ = drift · σ = volatility · θIₜ = IVNDX intervention
Intervention-Adjusted Baseline
dXᴵ = dX⁰ − η·u_{t−ℓ} dt
η = efficacy slider · u = intensity ($M deployed) · ℓ = lag (yrs)
Verified Surplus
S = q·m·(C(X⁰) − C(Xᴵ))₊
q = evaluator confirmation · m = collectability · (·)₊ = only positive savings count
Convex Government Cost Map
C(X) = c₀ + c₁X + c₂X² + c₃X³
Disorder compounds non-linearly · cubic cost acceleration · IVNDX flattens via Xᴵ
Fiscal Entropy
H = −Σᵢ pᵢ ln pᵢ
pᵢ = probability of cost state i · M states · higher H = more fiscal disorder
Syntropy — Entropy Reduction
Ω = H⁰ − Hᴵ
How much IVNDX intervention reduces fiscal disorder · amplifies PV via e^{βΩ}
Present Value with Syntropy Pricing
V₀ˢʸⁿ = Σₜ E₀[αₜ·e^{βΩ}·q·m·(C(X⁰)−C(Xᴵ))₊] / ∏(1+rᵤ+πᵤ)
α = payout share · β = syntropy sensitivity · r = discount rate · π = risk premium
Capital Efficiency Ratio
ℰₜ = dSₜ/dKₜ · 𝒟ₜ = −d²Sₜ/dKₜ²
ℰ > 1 means capital multiplies avoided costs · 𝒟 = deceleration of deployment efficiency
IVNDX Signal — Camden Social Domain
I_{Camden,t} = wσ·σ̂ + wκ·κ̂ + wλ·λ̂ + wΩ·Ω + wF·∂F/∂T
σ̂ = realized baseline volatility · κ̂ = cost convexity · λ̂ = crisis jump intensity · Ω = entropy reduction · ∂F/∂T = forward stress slope